Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Knowing when to change your investment strategy is crucial. Discover key signs that indicate it's time to adapt.
24,241 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Alphabet stock doubled year as the tech giant rode AI optimism and cloud growth. This guide breaks down what happened...
On March 12, investors navigated a mixed session in stock market today, march as a multi-day rally cooled. Hims And H...
Big banks are signaling a shift in U.S. stocks. This article breaks down three core reasons behind the downgrade and ...
When markets get choppy, consumer staples often become a safe harbor. This article compares Vanguard VDC and State St...
A security firm reports that researchers used Claude Mythos AI to help build a macOS kernel exploit. The incident spo...
As the AI-powered mood shifts, Micron faces pressure from memory-market concerns. This article breaks down what the m...
As June approaches, analysts watching closely into June are assessing AI ETF trends, liquidity, and risk. This guide ...
A prominent investor reduced its position in a leading sports tech stock, triggering a market rally of questions. Thi...
May delivered a powerful rally for chip stocks. This article explains why ishares semiconductor (SOXX) jumped 23% and...
When SpaceX surged, several smaller space stocks fell hard. Was it just rotation, or a signal to rethink the sector? ...
When a software icon trades at a discount to cash flow, investors ask one simple question: is this a bargain or a tra...